The Journal of Nutrition Health and Aging

, Volume 12, Issue 7, pp 433–450

Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives

Authors

    • Inserm, U558
    • University of Toulouse III
    • Department of Geriatric MedicineCHU Toulouse
  • S. Czerwinski
    • Department of Community Health, Lifespan Health Research Center, Boonshoft School of MedicineWright State University Dayton
  • G. Abellan van Kan
    • Department of Geriatric MedicineCHU Toulouse
  • J. E. Morley
    • Geriatric Research, Education and Clinical Center
    • Medical Center, and Division of Geriatric MedicineSaint Louis University
  • M. Cesari
    • Department of Aging and Geriatric ResearchUniversity of Florida - Institute on Aging
  • G. Onder
    • Department of Gerontological, Geriatric and Physiatric SciencesCatholic University of Sacred Heart
  • J. Woo
    • Division of geriatrics, Department of Medicine and Therapeutics. The Prince of Wales HospitalChinese University of Hong-Kong
  • R. Baumgartner
    • Department of Epidemiology and Population Health, School of Public Health and Information SciencesUniversity of Louisville
  • F. Pillard
    • Service d’Exploration de la Fonction Respiratoire et de Medecine du SportHôpital Larrey
  • Y. Boirie
    • UFR Médecine, UMR1019, Unité Nutrition HumaineUniversity Clermont 1
    • Clinical Nutrition UnitCHU Clermont-Ferrand
  • W. M. C. Chumlea
    • Department of Community Health, Lifespan Health Research Center, Boonshoft School of MedicineWright State University Dayton
  • B. Vellas
    • Inserm, U558
    • University of Toulouse III
    • Department of Geriatric MedicineCHU Toulouse
Article

DOI: 10.1007/BF02982704

Cite this article as:
Rolland, Y., Czerwinski, S., van Kan, G.A. et al. J Nutr Health Aging (2008) 12: 433. doi:10.1007/BF02982704

Abstract

Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older people.

Copyright information

© Springer-Verlag France and Serdi Éditions 2008